Clonal Diversity Drives Immunotherapy Response in Urothelial Cancer
In recent years, the intricate relationship between tumor biology and immune response has garnered significant attention, especially in the realm ...
In recent years, the intricate relationship between tumor biology and immune response has garnered significant attention, especially in the realm ...
In recent years, the treatment paradigm for non-small-cell lung cancer (NSCLC) has undergone a transformative shift, primarily driven by the ...
Lactic acid, once dismissed as a mere metabolic byproduct of glycolysis, has emerged as a potent and multifaceted regulator within ...
The Prognostic Power of Systemic Inflammation in Immunotherapy for Non-Small Cell Lung Cancer: New Meta-Analytical Insights Lung cancer remains a ...
A groundbreaking discovery from a collaborative team at the University of Chicago and the University of Pittsburgh has unveiled a ...
Research has unveiled groundbreaking insights into a novel antibody treatment that enhances the immune response of patients battling ovarian cancer. ...
Researchers at the University of Pittsburgh, in collaboration with UPMC Hillman Cancer Center, have recently unveiled groundbreaking findings that shift ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine